Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease

Annals of the American Thoracic Society

Volumn 11, Issue 3, 2014, Pages 303-309

  Desai, Himanshu ^a   Eschberger, Karen ^b   Wrona, Catherine ^b   Grove, Lori ^b   Agrawal, Aarti ^c   Grant, Brydon ^b,d   Yin, Jingjing ^b   Parameswaran, G Iyer ^b   Murphy, Timothy ^b   Sethi, Sanjay ^b  

^a Chesapeake Pulmonary and Critical Care Medicine   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c Infectious Disease Consultants of Hampton Roads   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Airway in flammation; Bacterial infection; Chronic obstructive pulmonary disease symptoms; Colonization

Indexed keywords

INTERLEUKIN 8;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BREATHLESSNESS COUGH AND SPUTUM SCALE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONFOUNDING VARIABLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; FEMALE; HAEMOPHILUS INFLUENZAE TYPE A; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LONGITUDINAL STUDY; LUNG FUNCTION; MALE; MIDDLE AGED; MORAXELLA CATARRHALIS; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; SPUTUM CULTURE; STATISTICAL ANALYSIS; STREPTOCOCCUS PNEUMONIAE; SYMPTOM; WEATHER; AGED; COMPLICATION; COUGH; DYSPNEA; HAEMOPHILUS INFLUENZAE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; SPUTUM;

AGED; COUGH; DYSPNEA; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; INTERLEUKIN-8; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MORAXELLA (BRANHAMELLA) CATARRHALIS; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM; STREPTOCOCCUS PNEUMONIAE;

EID: 84898726592     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201310-350OC     Document Type: Article

References (43)

1. Darkow T, Kadlubek PJ, Shah H, Phillips AL, Marton JP. A retrospective analysis of disability and its related costs among employees with chronic obstructive pulmonary disease. J Occup Environ Med 2007;49:22-30. (Pubitemid 46095587)
2. Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007;4:502- 506.
3. Mannino DM, Watt G, Hole D, Gillis C, Hart C, McConnachie A, Davey Smith G, Upton M, Hawthorne V, Sin DD, et al . The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006;27:627- 643.
4. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997;349:1436-1442. (Pubitemid 27212192)
5. Sethi S. Infection as a comorbidity of COPD. Eur Respir J 2010;35:1209-1215.
6. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359:2355-2365.
7. Rosell A, Monsó E, Soler N, Torres F, Angrill J, Riise G, Zalacaín R, Morera J, Torres A. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005; 165:891-897. (Pubitemid 40563235)
8. Bandi V, Apicella MA, Mason E, Murphy TF, Siddiqi A, Atmar RL, Greenberg SB. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med 2001;164:2114-2119. (Pubitemid 34020254)
9. Murphy TF, Brauer AL, Schiffmacher AT, Sethi S. Persistent colonization by Haemophilus in fluenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:266 -272.
10. Sethi S, Maloney J, Grove L, Wrona C, Berenson CS. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:991-998.
11. Banerjee D, Khair OA, Honeybourne D. Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD. Eur Respir J 2004;23:685-691. (Pubitemid 38618136)
12. Bresser P, Out TA, van Alphen L, Jansen HM, Lutter R. Airway in fl ammation in nonobstructive and obstructive chronic bronchitis with chronic Haemophilus in fl uenzae airway infection: comparison with noninfected patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162:947-952.
13. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J 1999;14:1015-1022.
14. Fuke S, Betsuyaku T, Nasuhara Y, Morikawa T, Katoh H, Nishimura M. Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2004;31:405-412. (Pubitemid 39330950)
15. O'Donnell RA, Peebles C, Ward JA, Daraker A, Angco G, Broberg P, Pierrou S, Lund J, Holgate ST, Davies DE, et al. Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax 2004;59:837-842. (Pubitemid 39389622)
16. Tanino M, Betsuyaku T, Takeyabu K, Tanino Y, Yamaguchi E, Miyamoto K, Nishimura M. Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema. Thorax 2002;57:405-411. (Pubitemid 34494150)
17. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-471. (Pubitemid 34879333)
18. Murphy TF, Brauer AL, Eschberger K, Lobbins P, Grove L, Cai X, Sethi S. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:853-860. (Pubitemid 351600663)
19. Murphy TF, Brauer AL, Grant BJ, Sethi S. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med 2005;172:195-199. (Pubitemid 40981193)
20. Desai H, Richter S, Doern G, Heilmann K, Dohrn C, Johnson A, Brauer A, Murphy T, Sethi S. Antibiotic resistance in sputum isolates of Streptococcus pneumoniae in chronic obstructive pulmonary disease is related to antibiotic exposure. COPD 2010;7:337-344.
21. Leidy NK, Rennard SI, Schmier J, Jones MK, Goldman M. The Breathlessness, Cough, and Sputum Scale: the development of empirically based guidelines for interpretation. Chest 2003;124:2182-2191. (Pubitemid 38010588)
22. Leidy NK, Schmier JK, Jones MK, Lloyd J, Rocchiccioli K. Evaluating symptoms in chronic obstructive pulmonary disease: validation of the Breathlessness, Cough, and Sputum Scale. Respir Med 2003;97 (Suppl A):S59-S70. (Pubitemid 36124432)
23. Mallia P, Message SD, Gielen V, Contoli M, Gray K, Kebadze T, Aniscenko J, Laza-Stanca V, Edwards MR, Slater L, et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 2011;183:734-742.
24. Walters EH, Walters J, Wills KE, Robinson A, Wood-Baker R. Clinical diaries in COPD: compliance and utility in predicting acute exacerbations. Int J Chron Obstruct Pulmon Dis 2012;7:427-435.
25. Earley MC, Vogt RF Jr, Shapiro HM, Mandy FF, Kellar KL, Bellisario R, Pass KA, Marti GE, Stewart CC, Hannon WH. Report from a workshop on multianalyte microsphere assays. Cytometry 2002;50:239-242.
26. Langsetmo L, Platt RW, Ernst P, Bourbeau J. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med 2008;177:396-401. (Pubitemid 351317582)
27. Xu W, Collet JP, Shapiro S, Lin Y, Yang T, Wang C, Bourbeau J. Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year. Eur Respir J 2010;35:1022-1030.
28. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847- 852.
29. Seemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1618-1623. (Pubitemid 33124148)
30. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-1422.
31. Sethi S, Wrona C, Eschberger K, Lobbins P, Cai X, Murphy TF. Inflammatory pro file of new bacterial strain exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:491-497. (Pubitemid 351442187)
32. Hurst JR, Wilkinson TM, Perera WR, Donaldson GC, Wedzicha JA. Relationships among bacteria, upper airway, lower airway, and systemic inflammation in COPD. Chest 2005;127:1219-1226. (Pubitemid 46224284)
33. Andersson F, Borg S, Jansson SA, Jonsson AC, Ericsson A, Prütz C, Rönmark E, Lundbäck B. The costs of exacerbations in chronic obstructive pulmonary disease (COPD). Respir Med 2002;96:700-708.
34. Marin A, Garcia-Aymerich J, Sauleda J, Belda J, Millares L, García-Núñez M, Serra I, Benet M, Agustí A, Antó JM, et al.; PAC-COPD Study Group. Effect of bronchial colonisation on airway and systemic inflammation in stable COPD. COPD 2012;9:121 -130.
35. Marin A, Monsó E, Garcia-Nuñez M, Sauleda J, Noguera A, Pons J, Agustí A, Morera J. Variability and effects of bronchial colonisation in patients with moderate COPD. Eur Respir J 2010;35:295-302.
36. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-1049. (Pubitemid 19247571)
37. Smith WB, Gamble JR, Clark-Lewis I, Vadas MA. Interleukin-8 induces neutrophil transendothelial migration. Immunology 1991;72:65 -72.
38. Curran T, Coyle PV, McManus TE, Kidney J, Coulter WA. Evaluation of real-time PCR for the detection and quantification of bacteria in chronic obstructive pulmonary disease. FEMS Immunol Med Microbiol 2007;50:112 -118.
39. Garcha DS, Thurston SJ, Patel AR, Mackay AJ, Goldring JJ, Donaldson GC, McHugh TD, Wedzicha JA. Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD. Thorax 2012;67:1075-1080.
40. Papaetis GS, Anastasakou E, Orphanidou D. Chlamydophila pneumoniae infection and COPD: more evidence for lack of evidence? Eur J Intern Med 2009;20:579-585.
41. Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, Gillissen A, Bufe A, Schultze-Werninghaus G. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 2003;58:37-42. (Pubitemid 36135356)
42. Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JA Jr, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, et al.; COPD Clinical Research Network. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 2011;365:689-698.
43. Sethi S, Jones PW, Theron MS, Miravitlles M, Rubinstein E, Wedzicha JA, Wilson R; PULSE Study Group. Pulsed moxi floxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Respir Res 2010;11:10.